Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

NKX2.5 mutations in patients with non-syndromic congenital heart disease

Full text
Author(s):
Gioli-Pereira, Luciana [1] ; Pereira, Alexandre Costa [2] ; Mesquita, Sonia M. [1] ; Xavier-Neto, Jose [1] ; Lopes, Antonio Augusto [1] ; Krieger, Jose Eduardo [1]
Total Authors: 6
Affiliation:
[1] Univ Sao Paulo, Sch Med, Div Pediat Cardiol, Heart Inst, InCor, BR-05403000 Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Med, Lab Genet & Cardiol Mol, InCor, HCFMUSP, BR-05403000 Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: INTERNATIONAL JOURNAL OF CARDIOLOGY; v. 138, n. 3, p. 261-265, FEB 4 2010.
Web of Science Citations: 33
Abstract

Background: Cardiac development is a complex and multifactorial biological process. Heterozygous mutations in the transcription factor NKX2.5 are between the first evidence of a genetic cause for congenital heart defects in human beings. In this study, we evaluated the presence and frequency of mutations in the NKX2.5 gene on 159 unrelated patients with a diverse range of non-syndromic congenital heart defects (conotruncal anomalies, septal defects, left-sided lesions, right-sided lesions, patent ductus arteriosus and Ebstein's anomaly). Methods: The coding region of the NKX2.5 locus was amplified by polymerase chain reaction and mutational analysis was performed using denaturing high performance liquid chromatography (DHPLC) and DNA sequencing. Results: We identified two distinct mutations in the NKX2.5 coding region among the 159 (1.26%) individuals evaluated. An Arg25Cys mutation was identified in a patient with Tetralogy of Fallot. The second mutation found was an Ala42Pro in a patient with Ebstein's anomaly. Conclusions: The association of NKX2.5 mutations is present in a small percentage of patients with non-syndromic congenital heart defects and may explain only a few cases of the disease. Screening strategies considering the identification of germ-line molecular defects in congenital heart disease are still unwarranted and should consider other genes besides NKX2.5. (C) 2008 Elsevier Ireland Ltd. All rights reserved. (AU)

FAPESP's process: 01/00009-0 - An integrated approach for the dissection of primary hypertension: molecular and functional characterization of the cardiovascular system
Grantee:Eduardo Moacyr Krieger
Support type: Research Projects - Thematic Grants